Repeals provisions relating to hemp extract for the treatment of intractable epilepsy
The repeal of section 195.207 will impact the legal landscape concerning the use of hemp extracts in Missouri. By eliminating restrictions on hemp extracts that were specifically defined under this section, the bill could facilitate broader access to hemp extracts for medical purposes, particularly for those suffering from intractable epilepsy. This may lead to further discussions on the regulation of hemp and cannabis products in the state, potentially aligning Missouri's laws with more progressive approaches seen in other states.
Senate Bill 874 aims to repeal section 195.207 of the Revised Statutes of Missouri, which relates to the use of hemp extract for the treatment of intractable epilepsy. The bill was introduced by Senator Bean to potentially ease the restrictions surrounding hemp extract, allowing for a more streamlined process for patients in need. The provision currently allows individuals with proper registration and certification to possess and use hemp extract without facing penalties, provided they meet specific criteria related to THC and CBD content.
While the repeal might provide increased access for patients in need of treatment for epilepsy, there could be opposing viewpoints concerning safety and regulatory oversight. Critics of the bill might raise concerns about the implications of deregulating hemp extract usage, questioning whether it could lead to misuse or a lack of quality control. Additionally, discussions around the appropriateness of repeal versus amendments to the existing framework could become a point of contention in legislative debates.